IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q3 2024 Holdings

Filed 2024-11-06 | 3 holdings | $162.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tango Therapeutics, Inc.(TNGX)COM87583X109$129.8M16,859,07580.1%
Pliant Therapeutics, Inc.(PLRX)COM729139105$23.9M2,132,86714.8%
Fulcrum Therapeutics, Inc.(FULC)COM359616109$8.4M2,343,1545.2%